Page last updated: 2024-12-06

dioxopromethazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

dioxopromethazine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID63031
CHEMBL ID3580712
MeSH IDM0050756

Synonyms (39)

Synonym
dioxopromethazine
9,9-dioxypromethazin
10h-phenothiazine-10-ethanamine,n,n,alpha-trimethyl-,5,5-dioxide
9,9-dioxopromethazine
10h-phenothiazine-10-ethanamine, n,n,alpha-trimethyl-, 5,5-dioxide
9,9-dioxo-10-(2-dimethylaminopropyl)-phenothiazinhydrochlorid [german]
5,5-dioxo-10-(2-(dimethylamino)propyl)phenothiazine hydrochloride
promethazine 5,5-dioxide
promethazine ss oxide
phenothizine, 10-(2-(dimethylamino)propyl)-, 5,5-dioxide
prothanon
1-(5,5-dioxophenothiazin-10-yl)-n,n-dimethylpropan-2-amine
FT-0656270
A807273
13754-56-8
1-(5,5-dioxo-10-phenothiazinyl)-n,n-dimethyl-2-propanamine
1-[5,5-bis(oxidanylidene)phenothiazin-10-yl]-n,n-dimethyl-propan-2-amine
dioxopromethazine hcl
dioxoprothazin
dioxopromethazin
6oot1mr6xs ,
unii-6oot1mr6xs
9,9-dioxo-10-(2-dimethylaminopropyl)-phenothiazinhydrochlorid
AKOS015896230
dioxopromethazine [who-dd]
dioxopromethazine, (+/-)-
10h-phenothiazine-10-ethanamine, n,n,.alpha.-trimethyl-, 5,5-dioxide
promethazine dioxide
CHEMBL3580712
AS-71332
10-[2-(dimethylamino)propyl]-10h-5??-phenothiazine-5,5-dione
DTXSID80929821
10-[2-(dimethylamino)propyl]-5lambda~6~-phenothiazine-5,5(10h)-dione
prothanon;9,9-dioxopromethazine; 9,9-dioxypromethazin
dioxoprothazine
BCP13644
Q27265239
HY-107787
CS-0030660
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (36.36)18.7374
1990's1 (9.09)18.2507
2000's5 (45.45)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (8.33%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]